391 related articles for article (PubMed ID: 27999207)
41. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
42. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
43. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism.
Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH
Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636
[TBL] [Abstract][Full Text] [Related]
44. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
[TBL] [Abstract][Full Text] [Related]
45. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
46. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
47. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies.
Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
[TBL] [Abstract][Full Text] [Related]
48. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
[TBL] [Abstract][Full Text] [Related]
49. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
50. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
Kent CN; Guttilla Reed IK
Clin Transl Oncol; 2016 Nov; 18(11):1056-1061. PubMed ID: 26856598
[TBL] [Abstract][Full Text] [Related]
51. [Research Progress of Regulation of Hypoxia-mediated Signaling Pathways on Epithelial-Mesenchymal Transition of Tumor Cells].
Chen C; Zhang X; Yang L; Lu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Jun; 33(3):575-82. PubMed ID: 29709162
[TBL] [Abstract][Full Text] [Related]
52. Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.
Fang D; Kitamura H
Int J Urol; 2018 Jan; 25(1):7-17. PubMed ID: 28697535
[TBL] [Abstract][Full Text] [Related]
53. GSK-3β-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
Park GB; Chung YH; Gong JH; Jin DH; Kim D
Int J Oncol; 2016 Nov; 49(5):2163-2172. PubMed ID: 27599658
[TBL] [Abstract][Full Text] [Related]
54. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
55. Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review).
Wu C; Zhuang Y; Jiang S; Liu S; Zhou J; Wu J; Teng Y; Xia B; Wang R; Zou X
Int J Oncol; 2016 Jun; 48(6):2236-46. PubMed ID: 27082441
[TBL] [Abstract][Full Text] [Related]
56. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
57. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
58. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
59. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.
Xu X; Zhu Y; Liang Z; Li S; Xu X; Wang X; Wu J; Hu Z; Meng S; Liu B; Qin J; Xie L; Zheng X
Cell Death Dis; 2016 Feb; 7(2):e2088. PubMed ID: 26844702
[TBL] [Abstract][Full Text] [Related]
60. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
